Controversy Surrounds Hims & Hers Super Bowl Ad: Health Experts and Senators Speak Out
2025-02-07
The New York Times
A highly anticipated Super Bowl ad from telehealth company Hims & Hers has sparked backlash from health experts and two US Senators, who are concerned about the spot's lofty claims regarding weight-loss drugs and lack of transparency about potential risks. With millions set to view the ad, critics argue it prioritizes marketing over safety and accurate information, highlighting the need for stricter regulations on prescription weight loss medications and diet pills. As the debate surrounding telehealth and weight loss solutions continues, Hims & Hers faces scrutiny over its advertising tactics.
